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The purpose of the study was to investigate a hypothesis proposed by Solms (2000) to the 
effect that a forebrain dopaminergic mechanism is the final common path to dreaming. It 
was hypothesised that sufferers of Parkinson's disease (PO) would have decreased 
intensity and frequency of dreams - that is that PO disease may lead to cessation or 
reduced dreaming, reduced duration of dreams, reduced narrative complexity of dream 
and a change in dream emotion and that this will further decrease with the duration of 
the disease irrespective of the medication that the patient is taking. Self-report 
questionnaires (N=40) and the Most Recent Dream Report (Oomhoff, 1996) was used for 
assessment. PO patients were found to have shorter as well as more pleasant dreams. A 
correlation (p < .05) was found in the PO sample between duration of illness and 
emotional quality of dreams and dream duration. The specific hypothesis of the study was 
not fully supported. However, the findings do support the suggestion that dreaming is 
generated by the mesocortical-mesolimbic dopamine system. 
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A study was done to ascertain the nature - specifically the intensity and frequency - of 
dreams in Parkinson's disease (PO) patients. The hypothesis investigated was that 
sufferers ofPD would have decreased intensity and frequency of dreams - that is, that PD 
may lead to cessation or reduced dreaming, reduced duration of dreams, reduced 
narrative complexity of dream and a change in dream emotion - and that this will further 
decrease with the duration of the disease irrespective of the medication that the patient is 
taking. The rationale of the study is to further attempt to confIrm the hypothesis that a 
dopaminergic mechanism "is the final common path to dreaming and that the 
[cholinergic] brainstem oscillator that controls rapid eye movement (REM) state is just 
one of the many arousal triggers that can activate this [dopaminergic] forebrain 
mechanism" (Solms, 2000 p. 843). 
1: Introduction 
Before the early 1950's sleep was seen as a unitary state. In 1953 and 1955 Aserinsky 
and Kleitman discovered rapid-eye-movement (REM) sleep, a period of sleep 
characterised by physiological activation, particularly eye-movement activity. The 
remainder of sleep came to be known as non-REM (NREM) sleep. By the 1960's the 
early monistic view of sleep was discarded in favour of this dualistic REM and NREM 
conception of sleep. Further research made the differences between the two states of 
sleep more apparent. REM sleep is characterised by activation in several systems -
changes in blood flow (Kanzow, Krause & KuhneL 1962), blood pressure (Snyder, 
Hobson & Goldfrank, 1963), hemt rate and regularity (Snyder, Hobson, Morrison & 
Goldfrank, 1964), respiration (Aserinsky, 1965: Snyder et at. 1964) and brain temperature 
(Kawamura & Sawyer, 1965; Reite & Pegram, 1968). It was also found that REM 
correlated very highly with subjective reports of dreams (Dement & Kleitman, 1957a; 
1957b) and consequently dreaming and the physiological state of REM sleep came to be 










It is currently accepted that sleep is composed of 5 cycles. The REM cycle alternates 
with the 4 other sleep cycles and occurs roughly every 90-100 minutes. About 25% of 
sleeping time in humans consists of REM sleep. Normal subjects report dreams 70 90% 
of the time on awakenings from REM sleep and 5-10% of the time on awakenings from 
NREM sleep (Dement & Kleitman, 1957a; 1957b; Hobson, 1988; Nielsen, 1999). These 
facts contributed greatly to the belief that dreaming and REM sleep are physiologically 
identical and that dreaming is just "an epiphenomenon of REM sleep" (Hobson, et a!., 
1998, p. R12; LaBruzza, 1978). Equating REM sleep with dreams also created the 
possibility of studying the neuronal mechanism of dreaming in animals, despite the fact 
that the subjective aspect of dreaming is necessarily inaccessible to the researcher and 
inaccessible to objective study. 
Several theoretical frameworks concerning the mechanisms for sleep and dreaming 
have been suggested. The most authoritative contemporary theory for sleep cycle control 
is the reciprocal-interaction model (RIM) proposed by McCarley and Hobson in 1975. 
The dominant (and closely related) neurological model for dream mechanisms is the 
activation-synthesis model (ASM) proposed by Hobson and McCarley in ]977. Both 
these models rely heavily on the REM = dream equation. Recently an alternative, 
dopaminergic hypothesis has been proposed by Solms (1997). "This hypothesis rests on 
the observation that dreaming and REM sleep are doubly dissociable states. That is, 
dreams can occur without REM, and REM can occur without dreams under both normal 
and pathological conditions" (Solms, 2001, p. 127). 
1.1 Theoretical framework 
1.1.1 Reciprocal interaction model (RI1H) 
The perception that the pontine brain stem contains the primary causal generator of 
dreaming and that dreaming is an epiphenomenon of REM sleep is still strong (Hobson, 
Stickgold & Pace-Schott, 1998). louvet (1962) demonstrated that the forebrain is 











generation, His conclusion that REM sleep is controlled by pontine brain stem 
mechanisms is still central to all main contemporary models of sleep cycle control. 
The RIM, as described by McCarley and Hobson (1975), is a structural and 
mathematical model for control of the desynchronised phase (REM) of the sleep cycle. 
The model suggests a reciprocal interaction between cells in the nucleus subcoeruleus 
and nucleus locus coeruleus (LC) and cells in the pontine gigantocellular tegmental Held 
(GTF). The necessary and sufficient cause of rapid eye movement (REM) sleep and 
dreaming is the firing of cholinoceptive.and/or cholinergic REM-on cells in the 
gigantocellular tegmental field of the pontine recticular formation (Aserinsky & 
Kleitman, 1953; 1955). During REM sleep the cells in the nucleus subcoeruleus and 
nucleus locus coeruleus are off and these aminergic (noradrenergic and serotonic) REM-
off cells provide the conditions for REM-on cells to fire. 
It is currently acknowledged by Hobson, (Hobson, Lydic & Baghdoyan, 1986) that 
their initial findings regarding this system are inadequate and that the whole network of 
nuclei giving effect to and contributing to this oscillatory mechanism is more widely 
distributed, Despite this their localization of the executive control of the REMlNREM 
cycle still lies narrowly within the pontine brain stem and the claim by Hobson and 
colleagues (1998), and that the cholinergic brainstem mechanisms cause REM sleep and 
dreaming, remains. The assertion that the forebrain is a passive participant in the REM 
state, that all the visual elements, and motor cortical events in REM sleep is induced by 
brain stem neurons, also still stand (Hobson, 1988; Hobson & McCarley, 1977; Sohns, 
2000), 
1.1.2 Activation synthesis mOllel (ASM) 
The ASM for human dreaming was formulated on the basis of brain stem-lesion 
research done in cats. This neurocognitive theory postulates that the cholinergic brain 
stem actively generates dreams and that dreams are passively synthesized by the 
forebrain. "The activated forebrain synthesizes the dreams by fitting experimental data to 
information endogenously and automatically generated by reticular, vestibular, and 











The proposal is that these cells not only trigger dreaming but that they also determine 
some of the unusual and bizarre formal features of dreaming. 
LL1, l. Psrch()logicaljmplicalil~n."; 
The psychological implications of the original version of this theory were the 
following - a) The primary motivating fDrce fDr dreaming is physiological. Thus, dreams 
have no psychological meaning or function, certainly not in the sense that Freudian 
theory proposed; b) ":-;pec{/ic stimuli/or the dream image!)' appear to arise 
intracerebrally but from the pontine brain stem and not in cognitive areas orthe 
cerebrum" and that the forebrain is "making the best of a bad job in producing even 
partially coherent dream imagery from the relatively noisy signals sent up to it from the 
brainstem" (Hobson & McCarley, 1977, p. 1347); c) The emotional, conceptual, and 
perceptual structures of the fDrebrain involved in the elaboration of the brain stem 
stimulus is seen as "primarily a synthetic constructive process, rather than a distorting 
one as Freud presumed" (Hobson & McCarley, 1977, p. 1374); d) The forgetting of 
dreams is attributed to a "state dependent amnesia" since a change of state, to waking, 
when carefully effected can produce good recall. This is directly related to the RIM -
"dream amnesia can now be modelled in a testable way as the result of a different balance 
between cholinergic and aminergic neuronal activity and the resulting effects on second 
messengers and macromolecules" (Hobson & McCarley, 1977, p. 1374). This leaves the 
notion of repression as an explanation fur the forgetting of dreams redundant. 
The clarity of dream vision is attributed to the activation of the visual system during 
REM sleep It is suggested that the ponto-geniculo-occipito (PGO) waves are responsible 
fDr the improbable constructions in dreams (Hobson, 1988). The theory offers no 
suggestions as to what cognitive (cerebrum/fDrebrain) processes might be active during 
dreaming and maintains that the causal stimuli for dreaming is the pontine brain stem and 
not the cognitive areas of the cerebrum/forebrain. lfwe accept that REM sleep, and thus 
dreaming, are controlled by the pontine brain stem mechanism then we also have to 










1.1.3 REM::j: Dreaming 
The assumption that REM sleep, and therefore dreaming, are controlled by the pontine 
brainstem is problematic as a) the correlation between REM sleep and dreaming is 
incomplete~ and b) because anticholinergic drugs and lesions on the cholinergic forebrain 
structures do not reduce or obliterate dreams (Solms, 2001). 
a) Early laboratory studies with humans elicited dream reports, although less "dream-
like'" and more "thought-like" than REM dreams, from NREM awakenings (Foulkes, 
1962; Foulkes & Schmidt, 1983 ; Foulkes & Vogel, 1965 ~ Herman, Ellman & Roftwarg, 
1978). Despite this, enough full-blown dream content was present to contradict the REM 
dreaming equation. The notion that REM dreaming was already abandoned by most 
dream researchers in the late 1960's (Domhoff, 2003). It is no longer disputed that 
dreaming can occur in the absence of REM and REM in the absence of dreaming, but the 
particular frequency of dreaming in NREM is still controversial (Solms, 2000) 
Foulkes (1962) found reports of complex mentation in over 50% ofNREM 
awakenings (with 50 -70% of dream reports at dream onset). Later studies placed the 
average at 43% (Nielsen, 1999). This indicates that at certain points in sleep there is a 
high dream presence without REM. However, not all REM and NREM dreaming are 
qualitatively the same, which raises the question of the extent to which NREM and REM 
dreaming may be equated. Monroe, Rechtschaffen, Foulkes & Jensen (1965) suggest in 
their study that roughly 10-30% ofNREM dreams cannot be distinguished from REM 
dreams, and even Hobson (1988) accepts the number of 5-1 0%. "lfwe adjust this 
conservative figure to account for the fact that NREM sleep occupies approximately 75% 
of total sleep time, this implies that roughly one quarter of all REM-like dreams occur 
outside REM sleep" (Solms, 2000. p. 845). 
The rising morning phase of the diurnal rhythm is accompanied by NREM dreaming 
which becomes exponentially greater in the late morning (Kondo, Anthrobus, & Fein, 
1989). This occurs to such an extent that sleep onset, in addition to late morning dreams, 











aminergically demodulated forebrain" (Solms, 2001, p. 125). None of this can be 
attributed to Hobson's theory. The ASM is therefore not sustainable. 
These findings, which have recently been confirmed by morning awakenings 
(Antrobus, Kondo, & Reinsel,l995; Cicogna, Natale, Occihionero, & Bosinelli, 1998) 
contributed to the modification of the activation-synthesis model and a retreat from the 
claim that the brain mechanisms that produce the REM state also produce dreams. The 
modified ASM has been called the AIM (activation, synthesis, input) model. 
1.1.4 AL'Yf (activation. sl'nthesis, input) 
The expanded ASM model, AIM (1 activation, 2. input 3. modulation) attributes a 
greater role to the forebrain in the regulation ofRE\1 sleep dreaming. This revised model 
takes into account all states of consciousness and not only dreaming by including two 
other areas that were previously neglected - input and neurochemical modulation. 
1. Aclimlion includes total and regional activation levels in the brain. The "global, 
regionally nonspecific picture of forebrain activation" has been replaced by "a 
preferential activation of limbic and paralimbic regions of the forebrain in REM" 
(Hobson, Pace-Schott, & Stickgold, 2000, p. 808). This implies that the forebrain is 
responsible for shaping dream plots through dream emotion rather than "playing a 
secondary role in dream plot instigation" (Hobson et a1., 2000, p. 808). 
2. Input "is a measure of the extent to which the brain-mind is processing external 
sensory data impinging upon receptors (as it is in waking) or from internal data sources 
(as in day-dreaming or REM sleep)" (Hobson et aL, 2000, p. 832). 
3. Aloduiafiol1 refers to the ratio of aminergic (ie serotonin and noreprinephrine) to 
cholinergic (i.e acetylcholine) chemical influence on the brain in each consciousness 
state. During waking the ratio is high. During REM it is reversed and serotonin and 
noreprinephrine levels are almost zero (Hobson et al, 2000). 
"In the full AIM model, waking is said to be characterized by high levels of brain 











characterized by high levels of brain activation, internal sources of input, and cholinergic 
modulation. NREM is characterized by low levels of brain activation, internal sources of 
input, and a mixture of aminergic and cholinergic modulation." (Domhoff, 2003, p.lSO). 
It is maintained that stimulation of the visual cortex through cholinergic 
neuroactivation is responsible for the visual/hallucinatory imagery of dreaming. The high 
level of activity in the basal ganglia is responsible for the ever present motion in dreams, 
and poor executive functions, including working memory, are responsible for the 
incongruency and discontinuity of dreams (Hobson et al., 2000) This model places less 
emphasis on the REM stage and NREM dreaming is attributed to subtle stimulation of the 
same area of the brain stern that produce REM sleep, the pontine tegmentum. Despite 
this change in the model the shift in theory went almost unnoticed because the notion that 
dreams are generated by pontine brainstem mechanisms was maintained. 
b) According to the ASM, which proposes (in both its classical and modified form) that 
dreams are synthesised by a cholinergically activated forebrain, it is expected that there 
should be a decrease in the frequency of dreaming and REM like mentation with the 
administration of anticholinergic medications and with damage to the cholinergic 
forebrain structures (Solms, 2001). This does not occur: as Cartwright (1966) observed 
anticholinergic drugs such as scopolamine and atropine actually intensify dreaming and 
dreamlike mentation - the opposite effect to what is expected according to AIM (see 
Ketchum et al., 1973; Perry & Perry, 1995 tor review). Many clinical cases have also 
been reported where vividness and frequency of dreaming increase after structural 
damage to the basal cholinergic forebrain nuclei (see Solms, 1997, for review). 
1. I. 5 Pontine brainstem dream generation 
The concept that dreams are generated by the pontine brainstem is further problematic 
as there is evidence that pontine brainstem damage does not cause loss of dreaming in 
humans. In domestic cats large lesions of the pontine brainstem result in the elimination 
of REM sleep. Twenty-six human cases with the same correlation have been reported 
(Adey, Bors & Porter, 1968; Chase, Moretti & Prensky, 1968; Cummings & Greenberg, 










1976: Osorio & Daron: J 980), Of the twenty-six cases loss of dreaming was only 
reported in one case (Feldman, 1971), but the location of lesion in this case was 
unce11ain, This does not necessarily indicate that preserved in such cases (Solms, 2000), 
However, there is some evidence that dreaming is maintained with pontine brain stem 
lesions, Solms (1997) reported clinical evidence, but not polygraphic data, for preserved 
dreaming in four patients with large pontine lesions, 
The assumption that dreaming is controlled by brainstem mechanisms will be difficult 
to refute by direct brainstem lesion data because extensive brain stem lesions are required 
to destroy both the REM and NREM components of the oscillator hypothesised to 
generate dreaming, Such lesions usually leave the patient unconscious, Indirect 
clinicoanatomical methods may, however, be used to refute the hypothesis by 
demonstrating that dreaming is eliminated in individuals with forebrain lesions who have 
a completely intact brain stem (Solms, 2000), 
1.1.6 The role o((orehrain meclumisms in drellm generation. 
The phenomenon of subjective loss of dreaming with forebrain lesions is not a new 
observation, Wilbrand (189211996) reported the first case in 1887 - his patient, who 
sutTered a bilateral occipitotemporal thrombosis, stopped dreaming almost completely, 
There are a further 1 09 published cases (including some in which the sleep cycle was 
evaluated) of cessation or near cessation of dreaming in individuals with focal forebrain 
lesions (Solms, 2000), Considering the widely accepted notion that REM sleep is the 
equivalent of dreaming, this lack of evidence for a correlation between dreaming and 
REM sleep is important. If the pontine brainstem is not the primary causal generator of 
dreaming then what causes humans to dream') 
In the abovementioned cases lesions were present in two forebrain regions - a) the 
transitional zone between the occipital, temporal, and parietal cortex, at the back of the 
forebrain, in or near the region of the parieto-temporo-occipital (PTO) junction; and b) in 
the \V'hite matter surrounding the frontal horns of the lateral ventricles, that is, the ventro-











targeted in modified frontal Jeucotomy which, in several large series resulted in a 70 
90% occurrence of complete or nearly complete loss of dreaming (Frank, 1946, 1950; 
Jus. Jus, Villeneuve, Pires, Lachane, Fortier & Villeneuve, 1973; Partridge, 1950, Piehler, 
1950; Schindler, 1953). 
Why should dreaming be lost with lesions in the ventromesial quadrant of the frontal 
lobes ') Solms (2000) proposed that REM sleep and dreaming are controlled by different 
brain mechanisms based on the discussed observation that RE!\1 sleep and dreaming are 
doubly dissociable states. He suggests that the mesolimbic and mesocortical 
dopaminergic systems playa role in dream activation. 
1.2 The Dopaminergic Hypothesis 
The ventromesial quadrant of the frontal lobes contains a considerable number of 
fibres linking frontal and limbic structures with dopaminergic cells in the ventral 
tegmentum. The source cells for the mesolimbic and mesocortical dopaminergic systems 
are situated in the ventral tegmental area of Tsai which ascend through the forebrain 
bundles of the lateral hypothalamus via the basal forebrain areas. They primarily 
terminate on the nucleus acumbens in the ventral striatum and also on the amygdala, 
anterior cingulate gyrus, and frontal cortex (Solms, 2000) 
This system, whose circuits bring about goal-seeking behaviours and self-satisfying 
interactions with the world, has been described as the "seeking" or "wanting" command 
system of the brain (Berridge, (in press); Panksepp, 1985, 1998). This system is also 
thought to have been primarily targeted in prefrontalleucotomies (Panksepp, 1985). 
Anti-psychotic medications, which block mesocortical-mesolimbic dopaminergic 
activity, also target this system (Role & Kelly, 199 I) and loss of interactive interest in the 
world is one of the main psychological effects of the drugs (Lehmann & Hanrahan, 1954; 
Panksepp, 1985) It is for this reason that anti-psychotic drugs are sometime described as 
'chemical leucotomies' (Breggin, 1980: Panksepp, 1985) This site is also thought to be 











Kelly, 1991) and the positive symptoms of schizophrenia are widely linked with 
overactivity of this system. These symptoms can also be induced by L-dopa, 
amphetamines and cocaine (Bird, 1990; Kandel, 1991; Panksepp, 1998). When this 
system is damaged it results in disorders typically marked by reduced interest, 
imagination, initiation and ability to plan ahead (Panksepp, 1985) with lack of initiative 
(adynamia) being a regular side effect of orbitomesial prefrontalleucotomy (Brown, 
1985) 
There are several factors that suggest that dreaming is generated by this mesocortical-
mesolimbic dopamine system. a) Following transection of the forebrain component of 
this circuit, dreaming ceases completely without any effect on REM sleep (Frank, 1946, 
1950; Jus et al. 1973; Partridge, 1950; Piehler, 1950; Schindler, 1953; Solms, 1997). b) 
Adynamia is a frequent side effect of the surgical transection of this circuit and 
characteristically accompanies loss of dreaming after deep frontal lesions. It also 
(statistically) distinguishes between dreaming and non-dreaming patients with such 
lesions (Sohns, 1997) c) Disproportionate and unusually vivid dreaming and nightmares 
as well as positive psychotic symptoms appear when this system is chemically activated 
by agents such as L-dopa (Nausieda, Weiner, Kaplan, Weber & Klawans, 1982), without 
affecting REM sleep (Hartman, Russ, Oldfield, Flake & Skoff 1980). d) Blocking 
activity in this circuit with drugs like haloperidol results in the inhibition of excessive, 
unusually frequent and vivid dreaming (Sacks, 1987, 1990, 1991) and other psychotic 
symptoms (Solms, 2000). e) Bartholini ( 1976) found that women treated with sulpiride 
(a DA blocking agent that acts mainly on mesolimbic DA neurons) experienced a marked 




There are four major dopamine systems in the brain: 
1. Extending from the hypothalamic nuclei to the median eminence. In this location 











2. Extending from the substantia nigra to the striatum (nigrostriatal sytem). This system 
is associated with motor activity of the basil ganglia and is the system that is most 
affected by PD. 
3. The mesolimbic system arises from cells in the ventral tegmental area of the ventral 
striatum and extends to the nucleus accumbens. 
4. The mesocortical system originates from cells in the ventral tegmental area and 
projects to the limbic and the prefrontal cortex (Clark & Boutros, 1999). Dreams are 
affected by the latter two systems. 
PD patients were chosen for this study because of the loss of dopaminergic cells that 
occur with the disease. PO is traditionally associated with degeneration of the 
nigrastriatal dopamine system (substantia nigra pars compacta) but recent studies show 
that the disease affects dopamine systems in a more widespread fashion than was 
previously thought. Loss of cells occurs in the pigmented substantia nigra zona 
compacta, which projects to the striatum. Pathology also occurs in the ventral tegmentum, 
the locus coeruleus, the serotonergic raphe nucleus, and the nucleus basalis ofMeynert 
(Bradshaw & Mattingley, 1995). In the ventral tegmentum area, dopaminergic neurons 
are affected with deficits in the lateral hypothalamus, amygdala, and the entorhinal, 
cinculate, hippocampal, and frontal cortices (Gupta, 1993). Dopamine containing cell 
groups such as the ventral tegmental area and the peri- and retrorubral region are affected 
albeit less so than the substantia nigra (Agid, Ruberg, Javoy-Agid, Hirsch, Raisman-
Vozaris, Vyas, Faucheux, Michel, Kastner, Blanchard, Damier, Villares & Zhang, 1993). 
Theory and research at this point suggests that a very specific group of forebrain 
structures are involved in dreaming including the anterior and lateral hypothalamic areas, 
amygdaloid complex, septal-ventral striatal areas; and the infralimbic, prelimbic, 
orbitofrontal anterior cingulate, entorhinal insular, and occipitotemporal corical areas 
(Braun, Balkin, Wesenten, Carson, Varga, Baldwin, Selbie, Belenky & Herscovitch, 
1997; Maquet, Peters, Aerts, Delfiore, Degueldre, Luxon & Franck, 1996; Nofzinger, 
Mintun, Wiseman, Kupfer & Moore, 1997). It is also of importance to note that the 











administration of dopaminergic agents, without affecting the trequency, intensity and 
duration of REM sleep in a similar manner (Hartman, et aI, 1980) 
Analysis of the major metabolite of dopamine, homovanallic acid, in living patients, 
and bioassay of the brains of deceased parkinsonian patients have demonstrated that brain 
dopamine is reduced by over 90 percent and often to imperceptible amounts. Thus, PO 
can be equated with a lack of dopamine (Kolb & Whishaw, 1980) which, in turn, we 
hypothesize should lead to less frequent and more impoverished dreaming. 
2.2 Dream research in Parkinsonian patients 
Sandyk, (1997) reports complete cessation of dreaming with the onset of PD. Chipolli, 
Bolzani, Massetani, Murri & Muratorio (1992, p. 522) found that the impairment of 
cognitive functioning due to PO did not result in an all or nothing effect but that there 
\vere quantitative differences in dreams of PO patients (on L-dopa with peripheral 
dopadecarboxylase inhibitors (D1») in relation to the outputs of the "higher-level 
processes of dream production, reflected in the sequential and structural characteristics of 
such patients' dreams". Both Chipolli et al (1992) and Massetani, Luchetti, Piccini, 
Bianchi, Maestrini and Muratorio (1986) found a higher dream recall rate in subjects on 
chronic L-dopa DI and found evidence of the unusual dream phenomena (qualitatively 
vivid, well organised and coherent, temporally condensed, seemingly real, and often 
affectively neutral) as described by Sharf et al. (1978). Massetani et at. (l986, p. 69) also 
found that "The Parkinsonian patient's dreams proved well-organised from a narrative 
point of view, closely linked to the subject's personal experience, often involving family 
environment, generally lacking bizarre elements and affectively neutral". According to 
Hall and Van de Castle's scale Parkinsonian dreams ditler to the normal population in the 
content of activity and emotivity in that emotional content and emotivity was scarce 
(Massetani et at. 1986). 
Little attention has been paid to dream organization and dream recall in PD patients 
with the majority of studies focusing on the effect of L-dopa on sleep patterns, 
hallucinations and altered dream phenomena. The literature indicates a 30-48% 











Goetz, Leurgans, Pappert, Raman & Sterner, 200 1; Pappel1, Christopher, Goetz, Prancie, 
Niederman, Raman & Leurgans, 1999; Scharf et al. 1997). None of the studies addressed 
dream phenomena before and after the onset of PD and the research only reports a return 
qldreams after the start of therapy (Kales, Ansel, Markham, Schart~ & Tan, 197 I; 
Kendel, Beck, \Vita, Hohneck, & Simmerman, 1972; Nausieda, 1987; Sandyk, 1997). 
The proposed study will focus on the subjective dream experience of PD sufferers 
assessing the nature of their current dream experiences, how it differs to premorbid dream 
experience, and lastly the relationship between the frequency and intensity of dreams and 
the duration of PD. 
3. Method 
3.1. Sample 
Twenty Parkinsonian patients (10 men and 10 women with a mean age of 68) were 
drawn from two private neurological practices according to the following criteria: 
a) The presence of idiopathic PD established by means of a neurological examination, 
symptoms including bradykinesia, rigidity, resting tremor, and impaired postural reflexes. 
Subjects were not assessed according to Hoehn and Yahr's (1967) scale. 
b) The absence of severe dementia and a history of previous functional psychosis. 
Subjects with a history of nonpsychotic psychiatric disorders or a family history of 
psychotic mental illness were not eliminated. 
c) There was no control for current treatment for Parkinson's disease. Medications 
include: Carbilev, Pergolite, Trianpexo\a, Artane, Levadopa, Selegiiine, Permax, 
Symmetrel, Sinemet, Medopar and Pexola. 
A control group consisting of 20 individuals with diabetic mellitus (DM) matched on 











All participants were fluent in English. Duration of PO since the first diagnosis ranged 
from 6 months to 14 years. Other illnesses: 1 PD patient reported depression that was at 
the time being treated with Effexor. Neither the depression not the medication affected 
his dreaming. Other illnesses reported were chronic lower back pain, thyroid, psoriasis, 
polymyalgia theumatica, high blood pressure, familial hyper triglyceridemia type 4, 
diverticulitus, hernia, spastic colon, prostrate, hypertension and migraine. 
3.2. Ethical Considerations 
The research was conducted with ethical oversight by the Department of Psychology 
Ethics Committee and the Groote Schuur Ethics Committee. Participation was voluntary. 
Informed written consent was obtained from participants prior to questionnaire 
administration, To ensure confidentiality each participant was allocated a number that 
appeared on their questionnaire for identification. The list containing participant's names 
and identification numbers were kept separately trom the questionnaires. All information 
was treated as strictly confidential. 
3.3. Instruments 
Self report questionnaires were administered to the participants. Survey instruments 
include: a) a Demographic Questionnaire, b) a Most Recent Dream report (Calvin S. Hall 
and Robert Van de Castle in Domhoff, 1966), and c) The Dream Interview (Solm5, 
1997) Questionnaires were formatted so as to require the minimum of writing to 
compensate for writing difficulties often experienced in PO, See Appendix A for 
Questionnaires. 
Demographic Questionnaire: The demographic questionnaire includes age, gender, 
home language, level of education, date of onset of symptoms, date of diagnosis of 
disease, medication and dosage, other medication and illness. 
Jt10sr recellf dream report: The Hall/Van de Castle system instruction (which is 











--Please describe the dream exactly and as fully as you can remember it. 
Your report should contain, whenever possible, a description of the setting 
of the dream, \vhether it was familiar to you or not; a description of the 
people, their sex, age, and relationship to you; and a description of any 
animals that appeared in the dream. If possible, describe your feelings 
during the dream and whether it was pleasant or unpleasant. Be sure to 
tell exactly what happened during the dream to you and the other 
characters. Please use the space provided and additional sheets if 
necessary" (Domhoff, 1996) 
Replication of normative findings on dream reports in the Hall/Van de Castle system 
provide a comparison point for studies of dream content globally and has been used in 
many different countries. Over 10 000 dream reports using this system have given 
consistent gender, developmental, and cross-cultural differences. Core findings are also 
stable across gender lines and cultural boundaries (Domhoff, 1997). 
lhe Dream Interview: The dream interview is based on a questionnaire developed by 
Mark Solms ( 1997) to assess whether or not (361) patients dreams have changed since 
the onset of their neurological illness, and if so, how the dreams have changed. The 
questionnaire approaches the neuropsychology of dreams from a clinical-descriptive 
viewpoint as opposed to a psychometric test score. The questionnaire thus evaluates 
patterns of change rather than quantitative deviation from a statistical measure of 
normality (Solms, 1997) Variables assessed are: sleep experience; presence of dreams; 
dream recall; narrative complexity of dreams; emotional quality of dreams; recurring 
nightmares; frequency of dreams; visual imagery of dreams: the ability to distinguish 
between dreams and real experiences; the length of dreams; dream content; and the 
influence of medication on dreams. Neither validity nor reliability of the scale has been 
tested. 
3.4. Procedure 
PD Patients were contacted by phone or letter by the respective neurologists informing 
them of the study, what it encompasses and asking if they might be interested in 











telephonically during the next week to give them more information on the study and to 
assess their willingness to participate. 
On telephonic contact the researcher clarified all questions regarding the study and 
informed the patients what was required from them in participation. They were given a 
choice of personal delivery and assistance in completing the questionnaire; having the 
questionnaires mailed to them: or having it emailed to them Mailed questionnaires 
included a stamped self-addressed return envelope. The researcher made it clear to all 
subjects that she was available to them at all times, both telephonically and/or for a 
personal visit. Participants were encouraged to ask assistance from the researcher, a 
ffiend, or tamily member to complete the form if they had difficulty in writing so as to 
prevent short and incomplete dream reports. The importance of a thorough and 
comprehensive dream report was stressed. 
DM out-patients were informed of the study by the head nurse in the ward after which 
they were approached by the researcher. 
3.5. Data recording and capturing: 
AJosl Recem Dream report: Three blind raters assessed the Most Recent Dream reports 
according to the following categories: element count; emotional quality; and narrative 
complexity. The following guidelines concerning each category were given to the raters: 
El ement~9.Jlnt 
Each new item, place or action in the dream constitutes an element. Once it has been 
scored it should not be scored again, e.g. 
Being chased by a man I all over a house!, down corridors, into rooms and Ihiding in 
placesl so he won't find me. Then escaping out of the windowl onto the roof! and into 
the garden. When 1 woke up I was really afraid. (7 elements) 
• In this instance corridors and rooms are covered by 'all over house' and are not 











• The subject's personal elaboration on the dream is not considered as part of the 
dream e,g, 'I was really afraid' is not part of the dream description but a 
subjective feedback on the emotional quality of the dream. 
• Any reference to how things are in reality in relation to the dream is not a dream 
element e,g, I am in a house with my sister (eldest) who, in reality I had an 
argument with, We were chatting/ when suddenly I hit her ... (3 elements) E.g. 
I returned to an old friend's house whom I worked with for one year. At first it 
was the wrong house (2 elements) 
• Tfthe subject mentions a book, movie or workplace and later mentions the title of 
the book/movie/workplace it should not be scored as a new element, but be 
considered as one element. 
• In depth descriptions of an object , " ,a R5 coin, it was hard shiny and si Iver' 
are classed together with the original element, i,e, the R5 (1 element) 
EmQtion<!l quality 
Is the dream pleasant, unpleasant or neutral') Often the dreamer her/himself indicates 
the emotional quality of the dream. In such an event the dream should be rated as 
perceived by the dreamer. In the absence of that the rater should interpret the dream 
according to the positive and negative emotions in the dream. 
Negative emotions: anger, apprehension, sadness, and confusion 
Positive emotions: varying degrees of happiness. 
Neutral: The absence of emotion in the dream. 
With (a) 1-3 = pleasant; (b)4 = neutral; (c )5-7 = unpleasant. Due to rater difficulties these 
were classed into categories a, b, and c, 
Narrative complexity 
1) Simple, straightforward, banal and mundane. 











The raters were initially given a small sample of dreams for training purposes. This 
sample of dreams was, as suggested by Domhoff (1996), chosen for their difficult coding 
decisions in order to highlight potential problem areas for the raters. Some ambiguities 
about coding will always exist in dream content studies and reports of a small percentage 
of the entire sample are generally responsible for the ambiguities. Rater agreement on 
most dreams is very high (Domhofl 1996). Problems were discussed by the raters and 
resolved where possible. 
Initially the percentage of perfect agreement for categories 'emotional quality' and 
'narrative complexity' was 75%. This was mainly due to difficulties in rating the 
emotional quality of dreams on a likert type scale. Good inter-rater reliability is only 
possible when one limits the categories of emotional states and does not attempt to 
differentiate levels of intensity (Domhoff, 1996). Once the scale was changed from 
measurement to categorical data into categories of pleasant, neutral and unpleasant the 
percentage of perfect agreement rose to 92%. 
The average correlation for element count between raters throughout the training 
session was r = 0.84. In the final exercise the correlation for element count between raters 
was calculated at r = 0.84. This score increased to r 0.93 when the results of a 
particularly difficult dream was removed from the pool. 
Ihe J)ream illlervieH': Data was captured in Excel and analysed using the Statistica 
statistics package. 
3.6. Data Analysis 
,Host recent dream report: Chi-square and correlation was used for the Most Recent 
Dream Report analysis. 
Demographic Questionnaire and The Dream imel'l'iell': A classical 2 x 2 chi-square 
tramework was used to compare the two groups. Due to the small sample size and the 











meaningfully and thus clinical description was relied on to supplement the formal 
statistical analyses. 
4. Results 
4.1. Dream presence (N=40): 
Of the 20 PD subjects three reported that they do not dream at night~ two subjects were 
uncertain if they dream at night; and fifteen confirmed the presence of dreams. All three 
subjects who do not dream at night cited that '1 do not know whether they dream or not 
but that 1 cannot recall my dreams'. One reported that dream cessation occurred qfter the 
onset of PD and the other two reported that dream cessation occurred prior to the 
diagnosis of the disease. The two subjects who were unsure if they dreamt stated that 
they think that they do dream but that they can't remember their dreams. Three subjects 
from the control group, the DM group, reported cessation of dreaming citing 'I do not 
know whether I dream or not but I can't recall my dreams' when asked why they think 
that they do not dream. None connected the cessation of dreaming to the onset of 
diabetes. 
Yes No Unsure 
PD 15 3 (1) 2(2) 
DM 17 3 (I) -
(1) I do not know "hether I dream or not but T can't recall my dreams. 
(2) I dream but I can't remember my dreams. 











4.2. The dream questionnaire: 
Statistically significant results are discussed first followed by statistically insignificant 
but clinically noteworthy results. See table 2 for the main features of the PD sample in 











Table 2: \1ain features of the PD sample in the dream questionnaire (N=20) 
Category 
Sleep 

















More simple b 











* Statistically significant at .05 level 
a: change in this direction 
















































4.2.1. Length oftlreams: 
The length of dreams in the PO group was significantly more varied than dream length 
in the DM group, (X2(3) 9.11, P < .05). In the PO group six participants reported that 
their dreams were unchanged; five reported shorter dreams; three reported longer dreams; 
and one was unsure. In the DM group fourteen subjects reported that their dreams were 
unchanged; and three that their dreams were longer since the onset of diabetes. 
Longel' Shorter L'nchanged Unsure 
PD 3 5 6 1 
DM 3 6 14 0 
Table 3: Location of the source of the significant difference in the length of dreams 
between PD and DM groups. 
4.2.2. EmotionlllqualiD' of dream ... : 
The PO group reported a change in the emotional quality of their dreams. (X2(3) 8.87. 
P <05) One participant reported that dreams were more unpleasant than before the 
onset of PO; six reported that their dreams were more pleasant than before; and seven 
reported no change. In group 2 two participants indicated that dreams were more 
unpleasant than before; fourteen indicated unchanged dreams; and one was unsure of any 










More More Unchanged Unsure 
pleasant unpleasant 
PO 6 1 X 0 
DM 0 2 14 I 
Table 4: Location of the source of the significant difference in the emotional quality of 
dreams between PD and DM groups. 
4.2.3. Narrative complexitv: 
This variable was very close to significance (X2(3) = 7.31, P = .06) and is worth 
mentioning considering the clinical importance of narrative complexity in dreams in this 
context. In the PD group four subjects reported that their dreams were more simple, 
straightforward, banal and mundane than before the onset of PD; three reported that their 
dreams are less simple and therefore more bizarre, incredible, convoluted and strange; 
seven reported that their dreams were unchanged in these respects; and one was unsure. 
In the DM group fourteen subjects reported no change; two indicated that their dreams 
are less simple and straight forward, and one was unsure. 
More Less Unchanged UnsUl·e 
simple simple 
PD 4 " 7 1 .) 
OM 0 2 14 1 









4.2.4. Duration ofPD in relation to emotionulqualitr and dream duration: 
A significant correlation (p .05) was found in the PO sample between duration of 
illness and emotional quality of dreams, and duration of illness and dream duration. There 
was not a significant con'e1ation between narrative complexity and duration of illness. 
4.3 The Most Recent Dream Report: 
Variables found to be significant or nearly significant in the questionnaire were 
assessed in the Most Recent Dream Report Variables assessed were emotional quality of 
dreams, length of dreams, and narrative complexity of dreams. 
4.3.1. EmotionulqualitJ, oft/reams: 
Emotional quality dreams, as in the questionnaire, resulted in a significant result X2(2) 
= 5.64, P < 05) The direction of change falls into the 'unpleasant' category for the OM 
group. 
Table 7: Direction of change in emotional quality of dreams in the Most Recent Dream 
Report. 
4.3.2. Length oft/reams: 
Unlike the self-report questionnaire that found that PD dreams are shorter since the 
onset of PO no statistically significant difference \vas found between word count and 












5.1. Dream frequency and presence: 
The present hypothesis derived from the dopamanergic hypothesis (Solms, 2000) 
which predicts that there will be a decrease in the frequency of dreams in PO patients due 
to the degeneration of the mesolimbic and mesocortical dopaminergic systems is not 
directly supported by this study. The Oopamanergic Hypothesis (Solms, 2000) suggests 
that the mesolimbic and mesocortical dopaminergic systems playa role in dream 
activation. Although this study did not find a statistically significant ditTerence between 
the PO and 01\1 groups in relation to dream presence it is of clinical interest to note that 
one PO patient, Mr. S.,l connected the cessation of dreaming to the onset of PO while 
two others reported that this symptom occurred prior to the onset of the diagnosis of the 
disease. In this sample the estimated mean duration of the disease before diagnosis is 1.7 
years with 6 years being the longest and 0 the shortest. Although some patients reported 
immediate diagnosis of the disease it is unlikely due to the progressive nature of the 
disease. It is therefore possible that PO related dream changes could have occurred in the 
earlier stages of the disease without the subject connecting the two phenomena. It should 
also be noted (as discussed in the limitations of the study) that some PO patients declined 
to participate in the research because they said that they could not recall dreams. None of 
the OM patients connected cessation of dreaming with their disease. This question thus 
begs further investigation. 
5.2. Length of dreams: 
PO patients reported their dreams to be shorter than before. Bartholini' s (1976) 
reported a decrease in dream duration in women treated with sulpiride, a OA blocking 
agent that acts mainly on mesolimbic OA neurons (there was no statistical difference in 
dream duration between men and women in the PO sample). Hartman et at. (1980) 
demonstrated that the length of dreams was increased with the administration of 
dopaminergic agents without atTecting the frequency, intensity and duration of REM 
j Mr S. was diagnosed with PD in 1989. He reported that he experienced some dmg related nightmares for 











sleep in a similar manner.Jn light of these two findings the decrease of dream length in 
PD patients can be reasonably attributed to a decrease of DA in the brain. 
Firstly, the decrease in dream duration possibly indicates that DA plays a role in dream 
activation in the sense that it is not necessarily needed to be present for dream activation 
per se but that it is necessary to consolidate the dream process. This does not support 
Hobson et aI's. (2000, p.808) suggestion that the forebrain is responsible for shaping 
dream plots through dream emotion rather than "playing a secondary role in dream plot 
instigation". If the forebrain is only involved in dream emotion there is no apparent 
reason why damage to this system should influence dream length. However, dream 
activation and continuance of the dream can be plausibly linked to each other therefore 
the mechanism that initiates the dream may also perpetuate the dream. The shorter 
dreams imply that the forebrain activation in not only involved in dream emotion (as will 
be seen in the discussion on emotional quality of dreams) but that it also plays a role in 
dream activation. Secondly_ the correlation between disease duration and shorter dreams 
further supports the above argument and SUppOlts Solms -s (2000) hypothesis that the 
mesocorticallmesolimbic system plays an active role in dream formation 
The subjective reporting by PD patients - that their dreams are shorter - was not 
supported by the raters findings on their Most Recent Dream report. One possible reason 
for this is that memory tends to favour emotionally salient dreams (Bednar, 2000). The 
overall subjective experience of dreaming might therefore be that the dreams are shorter 
but in reporting the most recent dream the patient might have elaborated and described 
dream phenomena in excessive detaiL Thus the subjective experience of a shorter dream 
is not evident in the dream report. This confound can be overcome by collecting morning 
recall questionnaires of sleep laboratory dream series from all participants as opposed to 
only the most recent dream. 
5. 3. Emotional quality of dreams: 
There is a significant difference in the emotional quality of dreams in both the self-
report questionnaire and the Most Recent Dream Report although the direction of change 











more pleasant than that of the DM group in the questionnaire while the raters found that 
the DM dreams were more unpleasant than the PD dreams. This was a surprise finding as 
the emotional quality of dreams in the PD sample was expected to be impoverished and 
atfectively neutral (Massetani et ai., 1986: Sohns, 2000). 
The questionnaire: Bartholini (1976) found a decrease in sexual and aggressive dream 
content in women treated with sulpiride (data on men is not available but DomhofT 
( 1996) reports that men tend to have more sexual dreams and are more aggressive in their 
dreams than women. No significant difference was tound between men and women for 
emotional quality of dreams within the PO sample). The same result can be reasonably 
expected from the process of DA depletion in PD. Both sexual and aggressive dream 
content are more often negatively experienced by the dreamer (Domhoff, 1996). A lower 
frequency of such elements in dreams may therefore make for less intense dreams and a 
more pleasant dream experience. 
Another possible explanation, which is compatible with the above finding. is the 
interaction of PO medication on a DA depleted brain. When the mesocorticallmesolimbic 
dopaminergic system is blocked loss of interactive interest in the world is one of the main 
psychological effects2 (Lehmann & Hanrahan, 1994; Panksepp, ] 985) Drugs like 
haloperidol (which cause the inhibition of the transport mechanism of cerebral 
monoamines, particularly by blocking the impulse transmission in dopaminergic neurons) 
cause the inhibition of disproportionate, unusually frequent and vivid dreaming (Sacks, 
] 987, 1990, 1991) and psychotic symptoms (Solms, 2000). When L-dopa is introduced 
to a healthy system positive symptoms of schizophrenia are induced (Bird, 1990; Kandel, 
] 99 I; Panksepp, 1998) as well as unusually vivid dreaming and nightmares (Nausieda, 
Weiner, Kaplan, Weber & Klawans, 1982). PO patients who are ()\'er medicated on L-
dopa also report the onset of nightmares (as was also reported by Mr. S) (Cipolli et al., 
1992; Goetz, Leurgans, Pappert, Raman & Sterner, 2001; Pappert, Christopher, Goetz, 
Prancie, Niederman, Raman & Leurgans, 1999; Scharf et aI. 1997). All PO patients in 
this study will have a lower than normal level ofDA in their system which, according to 
the effect of haloperidol should lead to a degree of dream inhibition. But all the PO 











patients are also currently on medication that increases DA in the system, therefore their 
dreams (if one considers the effects of L-dopa) may be stimulated to some degree. 
Therefore, if excess OA causes nightmares it is possible that in the near absence of 
natural DA the same medication in limited amounts may cause dreams to be experienced 
as more pleasant"' 
Ihe lv/osl Recent Dream Report: Dreams trom both groups were randomly divided 
between raters and blindly assessed in relation to each other. OM dreams were rated to be 
more unpleasant than PO dreams. Therefore, in relation to the PO dreams the OM dreams 
were unpleasant. Taking the above finding into consideration we argue that this does not 
indicate an abnormal unpleasantness in DM dreams but suggests a higher amount of 
pleasantness in the PD dream sample. These finding are therefore consistent. 
5.4. Narrative Complexitv: 
Although not statistically significant it is of clinical interest to note the distribution of 
the data on this question. Of the 15 PD dreamers 7 reported a change in their dreams 
with the majority of dream change lying in the simpler category (see table 4). Of the ] 7 
OM dreamers only 2 reported a change in their dreams with both reporting their dreams 
to be more complex. No DM patients reported their dreams to be simpler than before. 
This spread of data suggests a trend in the direction of dream narration in PO patients but 
the present study does not allow us to draw any conclusion as to what that might be. This 
important dream feature should be further investigated with the use of a larger sample in 
future studies. 
5.5. General discussion: 
The hypothesis of this study that PO patients will have less frequent and more 
impoverished dreaming as suggested by Solms is not fully supported. Nevertheless the 
results of this study support other aspects of the Dopaminergic hypothesis. Furthermore, 
.< Dream stimulation with smaller doses of L-dopa may occur to only such a degree that sexual and 
aggresshe dreams still tend to be more absent than in nonnal dreamers and therefore dreams seem more 











the results of the present study are incompatible with the AIM model proposed by 
Hobson (1988). 
It should be kept in mind that the DA system involved in PD is not exactly the same 
system proposed to be involved in dreams but that the two systems overlap. It is possible 
that PD patients are only mildly affected by the degeneration of the mesolimbic-
meso cortical DA system. The decrease in dream duration in the PO sample implies that 
the forebrain activation of the mesolimbic-mesocortical dopamine system is not only 
involved in dream emotion but also plays a part in sustaining dreams and possibly dream 
activation. When the forebrain component of this forebrain circuit is severed dreaming 
may cease completely without any effect on REM sleep (Frank, 1946, 1950; Jus et a1. 
1973; Partridge, 1950; Piehler, 1950; Schindler, 1953; Sohns, 1997). The decrease in 
dream length in PD patients and the cessation of dreaming in Me S. (whose pontine 
brainstem is intact) suggests that it is unlikely that the cholinergic brainstem mechanism 
is the cause of dreaming and that the forebrain is not just a passive participant in the REM 
state and synthesis of dreams. In light of the differences in dream length and emotion and 
the correlation between duration of PO and duration of illness and emotional quality of 
dreams, and duration of illness and dream duration we can not concede that dreaming is 
not controlled by forebrain mechanisms The question stands that if dreaming is reliant on 
the cholinergic activation of an aminergically demodulated forebrain why is there 
evidence of cessation of dreaming and shortening of dreams in PO patients with intact 
brainstems (Mr.S; Sandyk, 1997)'J 
Adynamia, a frequent side effect of PO, often occurs after the surgical transection of 
the mesocortical-mesolimbic dopamine circuit and typically accompanies loss of 
dreaming after deep frontal lesions. It also statistically distinguishes between dreaming 
and non-dreaming patients with such lesions (Solms, 1997). The mesolimbic-
mesocortical dopamine system in PO patients is not destroyed but the disease is 
recognised to reduce the levels of dopamine markedly. In such a degraded system one 
could therefore expect a change in dream phenomena, for example the shortening of 
dreams and emotional changes in dreams. One would not necessarily expect to see 











al. (1980) who demonstrated that the length of dreams were increased with the 
administration of dopaminergic agents without affecting the frequency, intensity and 
duration of REM sleep in a similar manner. 
The change in emotional quality of dreaming confirms that the DA mesolimbic-
mesocortical system plays an important role in dream emotion. Bartholini' s (1976) and 
Hartman's (1980) studies along with these results suggests specifically that the 
mesocortical-mesolimbic dopaminergic forebrain mechanism influences dream emotion. 
This motivating system whose circuits bring about goal-seeking behaviours and self-
satisfying interactions with the world, (Berridge, (in press); Panksepp, 1985, 1998) and 
also results in disproportionate and abnormally vivid dreaming and nightmares as well as 
positive psychotic symptoms when chemically activated (Nausieda, Weiner, Kaplan, 
Weber & Klawans, 1982) without affecting REM sleep (Hartman, Russ, Oldfield, Flake 
& Skotl 1980) appears to atTect dream themes, specifically aggressive or sexual dream 
content (Bartholini, 1976), which in turn determines the degree of pleasantness 
experienced in the dream (Domhoff, 1996). 
5.6. Limitations 
PD patients often have difficulty with writing and may find completing a questionnaire 
stressful. Care was taken to eliminate impoverished data reporting by suggesting to 
subjects to make use of the researcher, a friend, or a family member to complete the 
questionnaire in the event that the subject had difficulty in writing. DomhofT ( 1996) 
found no difference in the quality of self-written or verbal dream reports. Care was also 
taken to ensure that participants reported their most recent dream. There is a tendency in 
subjects, when they can't remember their most recent dream, to report either a recurring 
dream or a vivid dream experienced during childhood. Although Domhoff ( 1996) argues 
that the Most Recent Dream method gives a representative sample of all dreams 
Chapman and Underwood (2000) and Mealey (2000) pointed out that there is a tendency 
toward recalling dramatic and therefore more memorable dreams. A further tendency 
toward bias exists as it is estimated that only 5-1 O~/O of all dreams are recalled (Domhotl 











negative in that despite the tendency toward recall of vivid dreams emotional quality and 
length of dreams are sufficiently affected to be different from a normal population. 
Due to the nature of data collection a real danger of sample self selection existed. 
Several possible participants declined participation because they did not dream. The 
researcher tried to overcome this hurdle by stressing that all information on dreams, 
including the cessation of dreaming, was important and of interest to the study. 
A cross sectional study with sample size of 40 is considered adequate for the present 
exploratory study. The next suggested step is a longitudinal study matched on 
medication and dosage with a larger sample size. Although personality and cognitive 
variables do not influence dream recall and reporting (Domhoff, 1996) it is suggested that 
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I. Demographic Questionnaire 
J Most Recent Dream Report 











*F or the control group Parkinson's disease was substituted \"ith diabetes. 
The following is a series of questions about your current status as a Parkinson's 
disease (PD) patient. The questionnaire consists of three parts: 1) demographic 
details and medical history; 2) a most recent dream report; and 3) a dream 
assessment questionnaire. 
The questionnaire is voluntary you do not have to answer it if you do not want to. 
It is completely confidential. 
Please answer the questionnaires in the order that thev appear. Do not read the 
dream questionnaire before the com(}letion of your most recent dream report. 
]. Howald are you').. ......... 
2. What gender are you') (please circle the relevant sex) ........ Male Female 












1 1 Xitsonga 
12 Other 
4. What level of education do you have') (please indicate tertiary education as the 
number of years studied) 












5. When, more or less, was the onset ofPD symptoms') (please, if possible, specify the 
month and year, e.g. March 1997) 
6. When was the diagnosis made') (please specify the month and year, e.g. March] 997) 
7. What medication are you currently taking for PO'! 
8. What is the dosage') 
9. Are you taking any other medication,) (please circle) 
If yes, what medication are you taking? 
Yes 
10. Are you suffering from any other illnesses besides PD') (please circle) 
Yes No 













Your most recent dream 
We \vould like you to write down the last dream you remember having, whether it was 
last night, last week, or last month. But first please tell us the date (more or less) this 
dream occurred Then tell us what time of day you think you 
recalled it: 
~~~~~~~~~~ 
Please describe the dream exactly and as full y as you can remember it Your report 
should contain, whenever possible, a description of the setting of the dream, whether it 
was familiar to you or not; a description of the people, their sex, age, and relationship to 
you; and a description of any animals that appeared in the dream. I f possible, describe 
your feelings during the dream and whether it was pleasant or unpleasant. Be sure to tell 
exactly what happened during the dream to you and the other characters. Please use the 





















Dream Assessment Questionnaire 
The Dream Interview 
This questionnaire assesses if there have been any changes in your dreams since the 
onset of PD as well as specific aspects of your dreams. Please take your time to 
complete the questionnaire. 
I. Since the onset of PD, have you experienced your sleep to be 
a) better b) disrupted c) unafIected d) unsure if sleeping has been atrected 
2. Do you dream at night') 
a) yes b) no c) unsure 
2.1. If you answered no to question 2 please indicate why you think you do not dream at 
night 
a) I do not dream at all. 
b) I dream but can't remember my dreams. 
c) J do not know whether I dream or not but I can't recall mv dreams. 
2.2. Was this the case prior to the onset ofPD'J 
a) yes b) no 
If you answered YES to question 2 please continue with the questionnaire. 
3. Hmv has your ability to recall dreams (morning recall) been affected by PD? Has it 
become 











4. This question relates to the narrative complexity of your dreams. Are your dreams 
a) More simple, straightforward, banal and mundane than before the onset of PO? 
b) Less simple. straightforward, banal and mundane than before the onset of PO (ie, 
more bizarre, incredible, convoluted and strange),J 
c) Unchanged in these respects? 
d) Unsure. 
5. This question relates to the emotional qua] ity of your dreams. Do you feel that your 
dreams are 
a) More pleasant than before the onset of POt) 
b) More unpleasant than before the onset of PD 
c) Vnchanged from before? 
d) Unsure if there are any changes? 
6. This question relates to recurring nightmares. A recurring nightmare is the same 
nightmare dreamt on several occasions. 
recurring nightmares 
a) present'J b) absent? c) unsure. 
6.1. If you responded to question 6 with pre.<,ent. did this also occur before the onset of 
PO') 
a) yes b) no c) unsure 
7. This question relates to the frequency of your dreaming since the onset PD. 
Do you have 
a) More frequent dreams 
b) Less frequent dreams 












8. Has there been any change in the visual imagery in your dreams, for some people 
dream in black-and-white whereas they previously dreamt in colour, or they dream in 
static images Csnapshots') whereas they preciously dreamt kinematically. 
Visual imagery is 
a) changed b) unchanged 
8. t. If changed, please describe how your dreams have changed in this respect 
9. Is your dream-imagery 
a) More vivid or real than before the onset of PO') 
b) Less vivid or real than before the onset of PO') 
c) Unchanged in vivacity or reality,) 
d) Unsure 
10. Do you have difficulty distinguishing between dreams and real experiences (e.g 
when you wake up in the morning, you are initially unsure whether what you dreamt last 
night really happened or not). 
a) yes b) no 
10.1. If yes, was this always the case, or only since the onset of PO') 
a) always b) since the onset of PD 
I t. Do your dreams tend to be unusually long or display continuity over a single night, 















Il.l. Does the same dream sometimes continue all night'! 
a) yes b) no c) unsure 
t 1.2. If you answered yes to question 11., how often do you have continuous dreams':> 
a) more than once per week. 
b) once per week. 
c) once every two weeks. 
d) once per month. 
12. When dreaming, do you tend to dream of more recent (past 24 hours) experiences or 
more remote experiences,:> 
a) recent b) remote c) unsure 
12.1. Has there been any change in this respect since the onset of PO'! 
a) b) no c) unsure 
13. Have you noticed a change in your dreams since you staJ1ed taking PD medication':> 
a) yes b) no 
13.1. If yes, please describe how your dreams have changed. (e.g. did they become 












14. Do you experience day-time hallucinations') 
a) b) no 
15. Have you noticed any other changes in your dreams that have not been discussed in 
this questionnaire') If so, please indicate what they arc. 
-------------------------------_ ... __ .......... -
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